# Celanese Corp: Form 10-Q for the period ended Mar 31, 2018

- Company: [Celanese Corp](/companies/ce.md) (CIK 1306830)
- Form: 10-Q
- Filed: 2018-04-17
- Accepted by EDGAR: Apr 17, 2018, 16:40 ET
- Period: 2018-03-31
- Accession: 0001306830-18-000089
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1306830/000130683018000089/ce-10q33118.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1306830/000130683018000089/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2018-01-01 to 2018-03-31 | $1.34bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-01-01 to 2018-03-31 | $515.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-01-01 to 2018-03-31 | $18.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-01-01 to 2018-03-31 | $147.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-01-01 to 2018-03-31 | $343.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-01-01 to 2018-03-31 | $33.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-01-01 to 2018-03-31 | $65.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-01-01 to 2018-03-31 | $363.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-01-01 to 2018-03-31 | $2.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-01-01 to 2018-03-31 | $2.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-01-01 to 2018-03-31 | 136,383,735 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2018-01-01 to 2018-03-31 | $143.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2018-01-01 to 2018-03-31 | $86.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2018-01-01 to 2018-03-31 | $63.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2018-01-01 to 2018-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-03-31 | $490.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-03-31 | $3.01bn | us-gaap:AssetsCurrent |
| Total assets | at 2018-03-31 | $9.78bn | us-gaap:Assets |
| Current liabilities | at 2018-03-31 | $1.60bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2018-03-31 | $3.34bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2018-03-31 | $425.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2018-03-31 | $3.25bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2018-04-10 | 135,855,710 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1306830/000130683018000089/ce-10q33118.htm

Filed Apr 17, 2018.
Source: SEC EDGAR, the filing index for accession 0001306830-18-000089. Last ingested by Listed: Nov 13, 2026, 16:24 ET. No prices; not investment advice.
